The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

Jay Bhattacharya is director of the National Institutes of Health.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...

Experimental vaccines shrouded in controversy and targeted by health secretary Robert F Kennedy Jr may protect against one of ...

David Wallace-Wells and Emily Oster argue that the effects of MAHA will be long-lasting.

Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.

Discover the potential consequences of mRNA vaccine development cuts on poultry health and infectious disease management in ...

When U.S. Sen. Bill Cassidy decided to cast a key vote to confirm Robert F. Kennedy Jr. as Secretary of Health and Human ...